Navigation Links
Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
Date:2/7/2013

INDIANAPOLIS, Feb. 7, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will discontinue the Phase 3 rheumatoid arthritis (RA) program for tabalumab, an anti-BAFF (B cell activating factor) monoclonal antibody, due to lack of efficacy. The decision was not based on safety concerns. The tabalumab Phase 3 program for systemic lupus erythematosus, ILLUMINATE, is ongoing and will continue as planned.

In December 2012, Lilly discontinued the Phase 3 RA registration study FLEX-M for lack of treatment effect. FLEX-M was investigating tabalumab in patients with moderate-to-severe RA who had an inadequate response to methotrexate therapy.

Based on FLEX-M findings, an interim futility analysis was conducted of the FLEX-V study, which was investigating tabalumab for the treatment of patients with moderate-to-severe RA who had an inadequate response to one or more tumor necrosis factor (TNF) inhibitors.

Based on the outcomes of these two separate interim futility analyses, Lilly has decided to discontinue development of tabalumab in the current RA program. All ongoing Phase 2 and Phase 3 RA studies will be stopped.

"While we are obviously disappointed by these results in rheumatoid arthritis, we continue to believe that tabalumab could have significant potential for patients in other disease areas," said Eiry Roberts, M.D., vice president of autoimmune product development at Lilly. "Autoimmune disorders are highly individualized. We believe that targeting BAFF with a molecule such as tabalumab may still represent an important advance for patients, and therefore we will continue the ongoing Phase 3 tabalumab lupus program."

The decision to stop the current RA program for tabalumab is expected to result in a first-quarter charge to research and development expense of approximately $50 million. The compa
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Recognized for Fifth Straight Year on NAFEs Top 50 Companies for Executive Women
2. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
3. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
4. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
5. Lilly Provides Update on Next Steps for Solanezumab
6. Lilly to Expand Indianapolis Insulin Manufacturing Operations
7. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
8. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
9. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
10. Lilly Announces Results From Lung Cancer Study
11. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... from the board of directors and from his positions as ... most recently serving as the company,s president and chief operating ... join the board of directors.  Gary Lyons , a ... chairman. Mr. Gower is expected to remain an employee until ...
(Date:11/24/2014)... 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ... President and CEO of Inovio Pharmaceuticals, will be joined by ... the Nasdaq Opening Bell tomorrow, Tuesday November 25, 2014, at ... listing on the Nasdaq Global Select Market.  ... "We are honored to ring the Nasdaq Opening Bell on ...
(Date:11/22/2014)... N.C. , Nov. 22, 2014  Sprout Pharmaceuticals today ... which demonstrate that women treated with flibanserin up to 200 ... The data were presented at the 20 th Annual ... North America in Miami ... in response to the Complete Response Letter and the Formal ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Va., April 16 Insmed Inc. (Nasdaq:,INSM), a ... it has received approval from the United Kingdom,s ... the Company,s,first clinical study for a follow-on biologic ... form of human G-CSF, is a follow-on,biologic of ...
... Activity in a Variety of Tumor Types, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for ... the presentation of preclinical results for two of ... given by EntreMed,scientists during two poster sessions at ...
Cached Medicine Technology:Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 2EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 Medical suction ... 3.9 out of 5. This score represents steady growth ... three years to 2014 as a result of swelling ... suction machines, which are largely considered nondiscretionary. IBISWorld market ... process, buyers have some degree of flexibility, given the ...
(Date:11/26/2014)... Louisiana Back Institute, leaders of ... minimally invasive spine surgery, announces today the addition ... growing provider network of orthopedic spine surgeons and ... the network’s continuing success providing the most innovative ... who are suffering from orthopedic spine conditions and ...
(Date:11/26/2014)... One of the most important and vital ... her life is choosing the ideal wedding dress and ... to purchase high quality outfits. Today, BellasDress.com has unveiled ... can pick their suitable bridesmaid gowns here at discount ... ladies look scintillating and highlight all their most beautiful ...
(Date:11/26/2014)... News) -- Teens prescribed anti-anxiety or sleep medications ... than other teens, a new study warns. ... abuse assessments on teenagers before prescribing these drugs ... parents don,t realize the abuse potential," said lead ... of Michigan School of Nursing. "These drugs produce ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 (HealthDay ... and Drug Administration will have many restaurant chains posting calorie ... movie theater popcorn and ice cream parlor fare. "Americans ... often consuming less nutritious food and underestimating the calories they ... afternoon news conference. Although listing calorie counts on ...
Breaking Medicine News(10 mins):Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... to Improve Health: IOM-NAE Health Data Collegiate Challenge" was ... Academy of Engineering to promote interaction among future health ... harnessing new technologies and data to solve vexing health ... students studying engineering, computer science, and health disciplines to ...
... the human genetic code was mapped, expectations among scientists, health ... concerning the promise of genomics research for improving health. ... and bioethics experts cautions against the dangers of inflated expectations ... ways to avoid it while still realizing "the true ...
... Salamon HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay ... weeks early has no discernible impact on babies, a new ... than their full-term peers and those delays may affect their ... term and 1,200 late preterm infants -- those born between ...
... FL (Feb. 17, 2011) -- The 2nd Annual National Women ... 6 at the Hyatt Regency Clearwater Beach, featuring two of ... country as speakers. Keynote speakers will be ... Department of Surgery Surgeon-in-Chief, The Johns Hopkins Hospital, and Nancy ...
... THURSDAY, Feb. 17 (HealthDay News) -- Some 709,000 youngsters aged ... liquor and other alcoholic beverages, a new federal study found. ... drinkers aren,t just getting a friend to buy a six ... liquor cabinet. Some are getting the alcohol directly from a ...
... -- The area of the brain responsible for visual reading ... is a "task machine" instead of a "sensory machine," according ... measured neural activity in eight blind people while they read ... activity in the exact same part of the brain (visual ...
Cached Medicine News:Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2Health News:Promise of genomics research needs a realistic view 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 3Health News:National career symposium offers strategic advice to attract, advance women in surgery 2Health News:Many Kids Who Drink Get Liquor From Home: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 3
... Hybridizer hybridization ovens are designed to create the ... Temperature control (ambient to 99.9C) , Variable ... saturation of samples, whether it be for washing ... displays the current temperature inside the chamber, ,is ...
... circular clear acrylic chamber for complete visibility ... features microprocessor operation for precise mixing capability. ... Carousel rotates at 11 rpm; manufactured ... , Bottle Capacity - four 35 ...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Medicine Products: